FDA recall D-0857-2018
Teva Pharmaceuticals USA · Class III · drug
Product
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)
Reason for recall
Failed Stability Specifications
Distribution
United States
Key facts
- Status
- Terminated
- Initiation date
- 2018-04-30
- Report date
- 2018-05-30
- Termination date
- 2019-01-14
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- North Wales, PA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0857-2018